Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor

NCT00352534 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00352534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00352534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
November 6, 2006
Completion date
March 31, 2026
Enrollment
808 (actual)
Sites
240

Conditions

As the registry lists them; a condition with its own page is linked.

stage i kidney wilms tumor, stage ii kidney wilms tumor, stage iii kidney wilms tumor